Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators..

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.


Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy).

Naidu SS, Turco MA, Mauri L, Coolong A, Popma JJ, Kereiakes DJ.

Am J Cardiol. 2010 Apr 15;105(8):1060-4. doi: 10.1016/j.amjcard.2009.12.004. Epub 2010 Feb 20.


Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.

Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L.

Circulation. 2008 Feb 12;117(6):790-7. doi: 10.1161/CIRCULATIONAHA.106.651232. Epub 2008 Jan 22.


Understanding the drug-eluting stent trials.

Coolong A, Kuntz RE.

Am J Cardiol. 2007 Sep 3;100(5A):17K-24K. Epub 2007 Jun 26. Review.


Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial.

Holmes DR, Coolong A, O'Shaughnessy C, Chauhan M, Van Langenhove G, Hall P, Vermeersch P, Verlee P, Popma JJ, Cutlip D, Kuntz RE.

EuroIntervention. 2006 Aug;2(2):161-8.


Supplemental Content

Loading ...
Support Center